• Department of Neurology, West China Hospital of Sichuan University, Chengdu 610041, China;
HEli, Email: heli2003new@126.com
Export PDF Favorites Scan Get Citation

Objective To evaluate the efficacy and safety of all kinds of hemocoagulase on operative incisions. Methods Databases including Web of Science, MEDLINE, EMbase, EBSCO, PubMed, CNKI, WanFang Data and VIP were electronically searched to collect randomized controlled trials (RCTs) about hemocoagulase on operative incisions from the inception to June 20th, 2015. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then, meta-analysis was performed by RevMan 5.2 software. Results A total of 16 RCTs involving 1 867 patients were included. The results of meta-analysis showed that, compared with the control group, the hemostatic time (MD=-37.84, 95%CI -52.72 to -22.96, P<0.000 01), blood loss volume per unit area (MD=-0.09, 95%CI -0.10 to -0.07, P<0.000 01), PT of the first postoperative day (MD=-0.37, 95%CI -0.65 to -0.09, P=0.009) were significantly shorter in the hemocoagulase group. However, no significant differences were found in APTT, TT and FIB between two groups. Conclusion Hemocoagulase can reduce hemostatic time and blood loss volume in surgical incisions. Due to the limited quantity and quality of the included studies, the above conclusion needs to be further verified by more high quality studies.

Citation: YANGYa-qiong, CHENNing, GUOJian, HEli. Efficacy and Safety of Hemocoagulase on Surgical Incision: A Systematic Review. Chinese Journal of Evidence-Based Medicine, 2015, 15(11): 1309-1316. doi: 10.7507/1672-2531.20150215 Copy

  • Previous Article

    Efficacy and Safety of Recombinant Human TSH in Radioiodine Therapy for Benign Thyroid Goiter: A Meta-analysis
  • Next Article

    Effects of Exercise Therapy on Patients with Low Back Pain: A Meta-analysis